Attenuated Psychosis Syndromes Seen Through the Cultural Prism: Relevance, Terminology, and Book Structure

  • Daniel I. Shapiro
  • Huijun LiEmail author
  • Larry J. Seidman


People around the world, regardless of race, ethnicity, culture, social economic status, and geographic locations, suffer from mental illnesses, such as schizophrenia. Psychotic disorders are considered as one of the most debilitating mental illnesses in that they mostly start in youth, who are still undergoing mental and physical development, affect social and role functioning, and shorten life span by 25 years. Recently, relative international research efforts have been focused on early identification and early intervention of the prodromal or attenuated psychosis syndromes or clinical high risk for psychosis phase, a stage when subthreshold psychotic symptoms emerge and start to affect an individual’s daily function. Mental illnesses, such as attenuated psychosis syndromes, develop and get diagnosed and treated in a psychosocial biological context, which may differ by cultures. The purpose of this book is to present international perspectives on the identification and intervention of those at risk for psychosis. In this current chapter, we will introduce terminology related to attenuated psychosis syndromes. The structure of the whole book is also laid out in this chapter.


Attenuated psychosis syndrome Cultural relevance Terminology 


  1. Correll, C. U., Hauser, M., Auther, M., & Cornblatt, B. (2010). Research in people with the psychosis risk syndrome: A review of the current evidence and future directions. Journal of Child Psychology and Psychiatry, 51(4), 390–431. Scholar
  2. Huber, G., Gross, G., Schiittler, R., & Linz, M. (1980). Longitudinal studies of schizophrenic patients. Schizophrenia Bulletin, 6(4), 592–605. 1980.CrossRefGoogle Scholar
  3. Keith, S. J., & Matthews, S. M. (1991). The diagnosis of schizophrenia: A review of onset and duration issues. Schizophrenia Bulletin, 17(1), 51–67.CrossRefGoogle Scholar
  4. Klosterkötter, J., Ebel, H., Schultze-Lutter, F., & Steinmeyer, E. M. (1996). Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neuroscience, 246(3), 147–154.CrossRefGoogle Scholar
  5. Loebel, A. D., Lieberman, J. A., Alvir, J. M. J., Mayerhoff, D. I., Geisler, S. H., & Szymanski, S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry, 149(9), 1183–1188.CrossRefGoogle Scholar
  6. McGlashan, T., Walsh, B., Woods, S. (2010). The psychosis-risk syndrome: Handbook for diagnosis and follow-up. Oxford Publisher, New York.Google Scholar
  7. McGorry, P. D., Phillips, L. J., Kelly, D., Dell’Olio, M., Francey, S. M., … Buckby, J. (2005). Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian New Zealand Journal of Psychiatry, 39, 964–971.CrossRefGoogle Scholar
  8. McGorry, P. D., & Singh, B. S. (1995). Schizophrenia: Risk and possibility. In B. Raphael & G. D. Burrows (Eds.), Handbook of preventive psychiatry (pp. 492–514). Amsterdam: Elsevier.Google Scholar
  9. Moreno-Küstner, B., Martín, C., & Pastor, L. (2018). Prevalence of psychotic disorders and its association with methodological issues: A systematic review and meta-analyses. PLoS One, 13(4), e0195687.CrossRefGoogle Scholar
  10. Schultze-Lutter, F., Ruhrmann, S., Fusar-Poli, P., Bechdolf, A., Schimmelmann, B. G., & Klosterkötter, J. (2012). Basic symptoms and the prediction of first-episode psychosis. Current Pharmacological Design, 18(4), 351–357.CrossRefGoogle Scholar
  11. Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010). Schizophrenia, “just the facts”: Treatment and prevention. Past, present, and future. Schizophrenia Research, 122(1–3), 1–23.CrossRefGoogle Scholar
  12. Vigo, D., Thornicroft, G., & Atun, R. (2016). Estimating the true global burden of mental illness. The Lancet Psychiatry, 3, 171–178.CrossRefGoogle Scholar
  13. Woodberry, K. A., Shapiro, I. A., Bryant, C., & Seidman, L. J. (2016). Progress and future directions in research on the psychosis prodrome: A review for clinicians. Harvard Review of Psychiatry, 24, 87–103.CrossRefGoogle Scholar
  14. Yung, A. R. (2003). Commentary: The schizophrenia prodrome: A high-risk concept. Schizophrenia Bulletin, 29, 859–865.CrossRefGoogle Scholar
  15. Yung, A. R., & McGorry, P. D. (1996). The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin, 22, 353–370.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Daniel I. Shapiro
    • 1
    • 2
  • Huijun Li
    • 3
    Email author
  • Larry J. Seidman
    • 4
  1. 1.Department of PsychiatryEarly Psychosis Programs, University of California-DavisSacramentoUSA
  2. 2.Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA
  3. 3.Department of Psychology, College of Social Sciences, Arts and HumanitiesFlorida A&M UniversityTallahasseeUSA
  4. 4.Beth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA

Personalised recommendations